Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi-Aventis makes promotions and appointments

This article was originally published in Scrip

Executive Summary

Sanofi-Aventis has named Jean-Pierre Lehner senior vice-president and chief medical officer; he was formerly senior vice-president of medical and regulatory affairs. Laurence Debroux becomes senior vice-president and chief strategic officer; she was previously senior vice-president and chief financial officer, a position she will keep pending the appointment of a new CFO. Sanofi-Aventis has also announced that Dr Elias Zerhouni will become scientific advisor to its chief executive officer, Christopher Viehbacher, and to the senior vice-president of R&D, Marc Cluzel. Dr Zerhouni has won numerous awards for his research and most recently joined the Bill and Melinda Gates Foundation as a senior fellow.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC000139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel